Fosamax Osteonecrosis Lawyer
What is the FDA Doing?
- E-mail this Article
- Print this Article
- Text Size: A A
Editor: Tim O'Brien
Profession: Attorney at Law
Category: Drug information
Anyone concerned about Fosamax injuries and other safety concerns attending prescription medications should check out the recent article in the New England Journal of Medicine. Written By Dr. Jerry Avorn and Dr. Wiliam Shrank, the article addresses the danger of new moves by the FDA to limit manufacturer accountability for drug products. See article online.
Trackback Pings
TrackBack URL for this entry:
http://myblog.clarislaw.com/usa/mt-tb.cgi/647